|
According to that thread, "the official title of the study is UMCC 2006.119. Phase I/II Trial of MK-0752 followed by docetaxel in locally advanced or
metastatic breast cancer." The only restriction is that you can not be taxane refractory which unfortunately leaves a lot of people out...for now. Hopefully they'll see strong success and modify the taxane piece.
Eric
|